The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-5-methyl-N-((6-methyl-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)methyl)benzofuran-4-carboxamide ID: ALA4162406
Chembl Id: CHEMBL4162406
PubChem CID: 145962295
Max Phase: Preclinical
Molecular Formula: C25H28F3N3O4
Molecular Weight: 491.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCN(c1cc2occc2c(C(=O)NCc2c(C(F)(F)F)cc(C)[nH]c2=O)c1C)C1CCOCC1
Standard InChI: InChI=1S/C25H28F3N3O4/c1-4-31(16-5-8-34-9-6-16)20-12-21-17(7-10-35-21)22(15(20)3)24(33)29-13-18-19(25(26,27)28)11-14(2)30-23(18)32/h7,10-12,16H,4-6,8-9,13H2,1-3H3,(H,29,33)(H,30,32)
Standard InChI Key: JFONWYWBVOYASL-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 491.51Molecular Weight (Monoisotopic): 491.2032AlogP: 4.69#Rotatable Bonds: 6Polar Surface Area: 87.57Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.27CX Basic pKa: 3.43CX LogP: 2.61CX LogD: 2.61Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.52Np Likeness Score: -0.86
References 1. Lu B, Shen X, Zhang L, Liu D, Zhang C, Cao J, Shen R, Zhang J, Wang D, Wan H, Xu Z, Ho MH, Zhang M, Zhang L, He F, Tao W.. (2018) Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma., 9 (2): [PMID:29456795 ] [10.1021/acsmedchemlett.7b00437 ]